Invitae Corp NVTA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
2.54UNCH (UNCH)
Volume
23,818
Close
2.54quote price arrow up+0.10 (+4.10%)
Volume
7,299,294
52 week range
2.08 - 34.28
Loading...
  • Open2.46
  • Day High2.66
  • Day Low2.42
  • Prev Close2.44
  • 52 Week High34.28
  • 52 Week High Date07/02/21
  • 52 Week Low2.08
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap582.40M
  • Shares Out229.29M
  • 10 Day Average Volume13.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change-83.37

KEY STATS

  • Open2.46
  • Day High2.66
  • Day Low2.42
  • Prev Close2.44
  • 52 Week High34.28
  • 52 Week High Date07/02/21
  • 52 Week Low2.08
  • 52 Week Low Date06/14/22
  • Market Cap582.40M
  • Shares Out229.29M
  • 10 Day Average Volume13.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change-83.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.11
  • P/E (TTM)-1.21
  • Fwd P/E (NTM)-0.94
  • EBITDA (TTM)-401.512M
  • ROE (TTM)-17.29%
  • Revenue (TTM)480.52M
  • Gross Margin (TTM)22.94%
  • Net Margin (TTM)-93.93%
  • Debt To Equity (MRQ)56.06%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invitae Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and...
Eric Aguiar
Independent Chairman of the Board
Sean George Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Kenneth Knight
Chief Operating Officer
Yafei Wen
Chief Financial Officer
Robert Werner
Chief Accounting Officer
Address
458 BRANNAN STREET
San Francisco, CA
94107
United States

Top Peers

SYMBOLLASTCHG%CHG
ITOS
Iteos Therapeutics Inc
20.87+0.27+1.31%
RGNX
Regenxbio Inc
25.64+0.94+3.81%
ICPT
Intercept Pharmaceuticals Inc
14.13+0.32+2.32%
CHRS
Coherus BioSciences Inc
7.83+0.59+8.15%
MOR
MorphoSys AG
5.06+0.23+4.76%